Published in Pharma Law Weekly, May 13th, 2008
"Public policy analyses of the European Union's legislative process, however, show that intense lobbying by such interests can prevent legislative proposals from being adopted. even if economic interests were initially in favour of supranational legislation. How do we explain this apparent contradiction' The answer is that economic interests initially face great uncertainty as to the precise costs and benefits of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.